CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

26 hedge funds and large institutions have $10.6M invested in COSCIENS Biopharma Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
11
Reduced
2
Closed
6
Calls
$402K
Puts
$140K
Net Calls
+$262K
Net Calls Change
+$173K

Top Buyers

1
AL
1
AJO LP
Pennsylvania
$1.03M
2
EI
2
EAM Investors
California
$795K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$777K
4
Deutsche Bank
4
Deutsche Bank
Germany
$536K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$512K

Top Sellers

1
JGC
1
J. Goldman & Co
New York
$1.74M
2
AFM
2
Anson Funds Management
Texas
$0
3
BCM
3
Bridgeway Capital Management
Texas
$0
4
AAP
4
Ardsley Advisory Partners
Connecticut
$0
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
26
Bridgeway Capital Management
Texas
– -$326K -1,110 Closed
AAP
27
Ardsley Advisory Partners
Connecticut
– -$74K -250 Closed
Jane Street
28
Jane Street
New York
– -$30K -101 Closed
BlackRock
29
BlackRock
New York
– -$14K -49 Closed
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
– -$3K -9 Closed
1
2